NuMA function in nonmalignant and malignant breast cells

NuMA 在非恶性和恶性乳腺细胞中的功能

• 批准号: 7658226
• 负责人: SOPHIE A. LELIEVRE
• 金额: $ 21.05万
• 依托单位: PURDUE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-26 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7658226
• 关键词: Actins; Acute Promyelocytic Leukemia; Affect; Affinity Chromatography; Amino Acid Sequence; Antibodies; Architecture; Area; Behavior; Binding; Biochemistry; Blocking Antibodies; Breast; Cell Cycle Regulation; Cell Nucleus; Cell Proliferation; Cells; Characteristics; Chimeric Proteins; Chromatin; Chromatin Remodeling Factor; Chromatin Structure; Chromatography; Co-Immunoprecipitations; Complex; Data; Development; Disease; Distal; Environment; Epithelial; Epithelial Cells; Equilibrium; Euchromatin; Event; Extracellular Matrix; GAS41 gene; Gene Expression; Gene Expression Regulation; Genes; Genetic Transcription; Goals; Heterochromatin; Histones; ISWI; Indium; Interphase; Link; Location; Malignant - descriptor; Malignant Neoplasms; Mammary gland; Mediating; Medical; Mitotic; Mitotic spindle; Modeling; Molecular; Multiprotein Complexes; Mutate; Non-Malignant; Nuclear; Nuclear Protein; Nuclear Proteins; Peptides; Phenotype; Positioning Attribute; Premalignant; Proteins; Regulation; Relative (related person); Research; Research Personnel; Role; Shapes; Signal Pathway; Structural Protein; System; Testing; Therapeutic; Therapeutic Intervention; Time; Tretinoin; Work; base; calponin; cancer cell; chromatin remodeling; genetic regulatory protein; high risk; histone modification; innovation; leukemia; malignant breast neoplasm; member; neoplastic; neutrophil; novel; prevent; promoter; tumor; tumor progression

DESCRIPTION (provided by applicant): Alterations in chromatin structure and gene expression are a hallmark of cancer. Proteins involved in chromatin remodeling complexes (CRCs) directly affect chromatin structure by modifying DMA and histones, and CRCs targeting is altered in cancer. Structural proteins like NuMA, considered as organizers of nuclear architecture, also interact with chromatin, and their distribution is altered in cancer. However, the role of NuMA in the control of gene expression is unknown. NuMA co-isolates with components of ATP-dependent CRCs. Altering NuMA using an antibody against its C-terminus (CT) or by expressing the distal portion of its CT modifies chromatin structure and the phenotype of breast epithelial cells. CT-truncated NuMA and mutated NuMA are implicated in leukemia and breast cancer development, respectively. We propose to investigate the mechanisms by which NuMA controls chromatin structure and gene expression in breast epithelial cells. The hypothesis is that NuMA participates in the control of gene transcription by interacting with components of CRCs, in order to target these complexes to specific genes. Three aims are proposed: (1) To identify the specific CRCs in which NuMA is involved by assessing the interaction of NuMA with components of SNF2h and BAF types of ATP-dependent CRCs by affinity chromatography and co- immunoprecipitation, and assessing the effect of inhibiting NuMA expression on the assembly and function of CRCs; (2) To analyze the primary sequence of NuMA with regards to its involvement in chromatin regulation by comparing the effects of interrupting the function of HPC2-like, GAS41-binding, and CH-binding regions of NuMA on chromatin organization, CRC function, and mammary epithelial differentiation; (3) To define the role of NuMA in gene expression control by position effect, by interfering with NuMA function and evaluating the expression status (on or off) of genes that control cell proliferation in relation to their localization and the presence of NuMA-containing CRCs at their promoter. Significance: A current scientific and medical challenge is to unravel the mechanisms that underlie changes in the machinery or regulation of gene expression during cancer development. Understanding these mechanisms will help develop strategies to prevent cancer progression and control tumor behavior. Thus, it is time to emphasize the role of structural nuclear proteins in gene transcription in order to get a complete picture of gene expression control.

描述（由申请人提供）：染色质结构和基因表达的改变是癌症的标志。参与染色质重塑复合体（CRCs）的蛋白质通过修饰DMA和组蛋白直接影响染色质结构，而CRCs的靶向性在癌症中发生改变。像NuMA这样的结构蛋白，被认为是核结构的组织者，也与染色质相互作用，它们的分布在癌症中发生了改变。然而，NuMA在控制基因表达中的作用尚不清楚。NuMA与atp依赖性crc组分共分离。使用针对其c端（CT）的抗体或通过表达其CT的远端部分来改变NuMA，可以改变乳腺上皮细胞的染色质结构和表型。ct截短的NuMA和突变的NuMA分别与白血病和乳腺癌的发展有关。我们建议研究NuMA控制乳腺上皮细胞染色质结构和基因表达的机制。假设NuMA通过与crc的组分相互作用参与基因转录的控制，从而将这些复合物靶向特定基因。本文提出了三个目标：(1)通过亲和层析和共免疫沉淀的方法，评估NuMA与SNF2h和BAF型atp依赖性crc组分的相互作用，确定NuMA参与的特异性crc，并评估抑制NuMA表达对crc组装和功能的影响；(2)通过比较中断NuMA的hpc2样区、gas41结合区和ch结合区功能对染色质组织、结直肠癌功能和乳腺上皮分化的影响，分析NuMA参与染色质调控的初级序列；(3)通过位置效应来确定NuMA在基因表达控制中的作用，通过干扰NuMA功能，评估控制细胞增殖的基因的表达状态（开启或关闭），以及它们的启动子中含有NuMA的crc的存在。意义：当前的科学和医学挑战是揭示癌症发展过程中基因表达机制或调控变化的潜在机制。了解这些机制将有助于制定预防癌症进展和控制肿瘤行为的策略。因此，是时候强调结构核蛋白在基因转录中的作用，以获得基因表达控制的完整图景。